 | • レポートコード：QY2108PAL8903 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける経口ワクチンの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、経口ワクチンの種類別市場規模（ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン）、用途別市場規模（公共用、個人用）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の経口ワクチン市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における経口ワクチンの種類別市場規模（2016年-2027年）：ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン ・世界における経口ワクチンの用途別市場規模（2016年-2027年）：公共用、個人用 ・経口ワクチンの中国市場分析 - 経口ワクチンの中国市場規模（2016年-2027年） - 中国における経口ワクチンの主要プレイヤー別市場シェア - 中国における経口ワクチンの種類別市場規模：ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン - 中国における経口ワクチンの用途別市場規模：公共用、個人用 ・経口ワクチンの北米市場（2016年-2027年） ・経口ワクチンのヨーロッパ市場（2016年-2027年） ・経口ワクチンのアジア太平洋市場（2016年-2027年） ・経口ワクチンの中南米市場（2016年-2027年） ・経口ワクチンの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Merck、GSK、Sanofi、Lanzhou Institute、Serum Institute、Valneva、Shanghai United Cell、Bibcol、PaxVax、Vabiotech、Tiantan Biological、EuBiologics、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
Market Analysis and Insights: Global and China Oral Vaccines Market
This report focuses on global and China Oral Vaccines market.
In 2020, the global Oral Vaccines market size was US$ 2325 million and it is expected to reach US$ 3185 million by the end of 2027, with a CAGR of 4.3% during 2021-2027. In China the Oral Vaccines market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Oral Vaccines Scope and Market Size
Oral Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Oral Vaccines market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Segment by Application
Public
Private
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
1 Study Coverage
1.1 Oral Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Oral Vaccines Market Size Growth Rate by Type
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Market by Application
1.3.1 Global Oral Vaccines Market Size Growth Rate by Application
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Oral Vaccines Revenue 2016-2027
2.1.2 Global Oral Vaccines Sales 2016-2027
2.2 Global Oral Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Oral Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Oral Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Oral Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Oral Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Oral Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Oral Vaccines Revenue Forecast by Region (2022-2027)
3 Global Oral Vaccines Competitor Landscape by Players
3.1 Global Top Oral Vaccines Manufacturers by Sales
3.1.1 Global Oral Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Oral Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Oral Vaccines Manufacturers by Revenue
3.2.1 Key Oral Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Oral Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Oral Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oral Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Oral Vaccines Revenue in 2020
3.2.6 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Oral Vaccines Price by Manufacturers
3.4 Global Oral Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Oral Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Oral Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Oral Vaccines Market Size by Type (2016-2021)
4.1.1 Global Oral Vaccines Sales by Type (2016-2021)
4.1.2 Global Oral Vaccines Revenue by Type (2016-2021)
4.1.3 Oral Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Oral Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Oral Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Oral Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Oral Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Oral Vaccines Market Size by Application (2016-2021)
5.1.1 Global Oral Vaccines Sales by Application (2016-2021)
5.1.2 Global Oral Vaccines Revenue by Application (2016-2021)
5.1.3 Oral Vaccines Price by Application (2016-2021)
5.2 Oral Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Oral Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Oral Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Oral Vaccines Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Oral Vaccines Market Size YoY Growth 2016-2027
6.1.1 China Oral Vaccines Sales YoY Growth 2016-2027
6.1.2 China Oral Vaccines Revenue YoY Growth 2016-2027
6.1.3 China Oral Vaccines Market Share in Global Market 2016-2027
6.2 China Oral Vaccines Market Size by Players (International and Local Players)
6.2.1 China Top Oral Vaccines Players by Sales (2016-2021)
6.2.2 China Top Oral Vaccines Players by Revenue (2016-2021)
6.3 China Oral Vaccines Historic Market Review by Type (2016-2021)
6.3.1 China Oral Vaccines Sales Market Share by Type (2016-2021)
6.3.2 China Oral Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 China Oral Vaccines Price by Type (2016-2021)
6.4 China Oral Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Oral Vaccines Sales Forecast by Type (2022-2027)
6.4.2 China Oral Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 China Oral Vaccines Price Forecast by Type (2022-2027)
6.5 China Oral Vaccines Historic Market Review by Application (2016-2021)
6.5.1 China Oral Vaccines Sales Market Share by Application (2016-2021)
6.5.2 China Oral Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 China Oral Vaccines Price by Application (2016-2021)
6.6 China Oral Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Oral Vaccines Sales Forecast by Application (2022-2027)
6.6.2 China Oral Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 China Oral Vaccines Price Forecast by Application (2022-2027)
7 North America
7.1 North America Oral Vaccines Market Size YoY Growth 2016-2027
7.2 North America Oral Vaccines Market Facts & Figures by Country
7.2.1 North America Oral Vaccines Sales by Country (2016-2021)
7.2.2 North America Oral Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Oral Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Oral Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Oral Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Oral Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Oral Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Oral Vaccines Market Facts & Figures by Country
9.2.1 Europe Oral Vaccines Sales by Country (2016-2021)
9.2.2 Europe Oral Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Oral Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Oral Vaccines Market Facts & Figures by Country
10.2.1 Latin America Oral Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Oral Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oral Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Oral Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Oral Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Oral Vaccines Products Offered
12.1.5 Merck Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Description and Business Overview
12.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Oral Vaccines Products Offered
12.2.5 GSK Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Description and Business Overview
12.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Oral Vaccines Products Offered
12.3.5 Sanofi Recent Development
12.4 Lanzhou Institute
12.4.1 Lanzhou Institute Corporation Information
12.4.2 Lanzhou Institute Description and Business Overview
12.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lanzhou Institute Oral Vaccines Products Offered
12.4.5 Lanzhou Institute Recent Development
12.5 Serum Institute
12.5.1 Serum Institute Corporation Information
12.5.2 Serum Institute Description and Business Overview
12.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Serum Institute Oral Vaccines Products Offered
12.5.5 Serum Institute Recent Development
12.6 Valneva
12.6.1 Valneva Corporation Information
12.6.2 Valneva Description and Business Overview
12.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Valneva Oral Vaccines Products Offered
12.6.5 Valneva Recent Development
12.7 Shanghai United Cell
12.7.1 Shanghai United Cell Corporation Information
12.7.2 Shanghai United Cell Description and Business Overview
12.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Shanghai United Cell Oral Vaccines Products Offered
12.7.5 Shanghai United Cell Recent Development
12.8 Bibcol
12.8.1 Bibcol Corporation Information
12.8.2 Bibcol Description and Business Overview
12.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bibcol Oral Vaccines Products Offered
12.8.5 Bibcol Recent Development
12.9 PaxVax
12.9.1 PaxVax Corporation Information
12.9.2 PaxVax Description and Business Overview
12.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 PaxVax Oral Vaccines Products Offered
12.9.5 PaxVax Recent Development
12.10 Vabiotech
12.10.1 Vabiotech Corporation Information
12.10.2 Vabiotech Description and Business Overview
12.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Vabiotech Oral Vaccines Products Offered
12.10.5 Vabiotech Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Oral Vaccines Products Offered
12.11.5 Merck Recent Development
12.12 EuBiologics
12.12.1 EuBiologics Corporation Information
12.12.2 EuBiologics Description and Business Overview
12.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 EuBiologics Products Offered
12.12.5 EuBiologics Recent Development
12.13 Panacea Biotec Ltd
12.13.1 Panacea Biotec Ltd Corporation Information
12.13.2 Panacea Biotec Ltd Description and Business Overview
12.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Panacea Biotec Ltd Products Offered
12.13.5 Panacea Biotec Ltd Recent Development
12.14 Bio-Med
12.14.1 Bio-Med Corporation Information
12.14.2 Bio-Med Description and Business Overview
12.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Bio-Med Products Offered
12.14.5 Bio-Med Recent Development
12.15 Halfkin Bio-Pharmaceuticals
12.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
12.15.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
12.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Halfkin Bio-Pharmaceuticals Products Offered
12.15.5 Halfkin Bio-Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Oral Vaccines Industry Trends
13.2 Oral Vaccines Market Drivers
13.3 Oral Vaccines Market Challenges
13.4 Oral Vaccines Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Oral Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Rotavirus Vaccine
Table 3. Major Manufacturers of Cholera Vaccine
Table 4. Major Manufacturers of Oral Polio Vaccine
Table 5. Global Oral Vaccines Market Size Growth Rate by Application (2021-2027) & (M Doses)
Table 6. Global Oral Vaccines Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Oral Vaccines Sales by Regions (2016-2021) & (M Doses)
Table 8. Global Oral Vaccines Sales Market Share by Regions (2016-2021)
Table 9. Global Oral Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Oral Vaccines Sales Forecast by Region (2022-2027) & (M Doses)
Table 11. Global Oral Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Oral Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Oral Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Oral Vaccines Sales by Manufacturers (2016-2021) (M Doses)
Table 15. Global Oral Vaccines Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Oral Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 17. Oral Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Oral Vaccines Revenue Share by Manufacturers (2016-2021)
Table 19. Global Oral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Oral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Vaccines as of 2020)
Table 21. Key Manufacturers Oral Vaccines Price (2016-2021) (USD/K Doses)
Table 22. Oral Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Oral Vaccines Product Type
Table 24. Date of International Manufacturers Enter into Oral Vaccines Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Vaccines Sales by Type (2016-2021) (M Doses)
Table 27. Global Oral Vaccines Sales Share by Type (2016-2021)
Table 28. Global Oral Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Oral Vaccines Revenue Share by Type (2016-2021)
Table 30. Oral Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/K Doses)
Table 31. Global Oral Vaccines Sales Forecast by Type (2022-2027) & (M Doses)
Table 32. Global Oral Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Oral Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Oral Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Oral Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/K Doses)
Table 36. Global Oral Vaccines Sales by Application (2016-2021) (M Doses)
Table 37. Global Oral Vaccines Sales Share by Application (2016-2021)
Table 38. Global Oral Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Oral Vaccines Revenue Share by Application (2016-2021)
Table 40. Oral Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/K Doses)
Table 41. Global Oral Vaccines Sales Forecast by Application (2022-2027) & (M Doses)
Table 42. Global Oral Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Oral Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Oral Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Oral Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/K Doses)
Table 46. China Oral Vaccines Sales (M Doses) of Key Companies (2016-2021)
Table 47. China Oral Vaccines Sales Share by Company (2016-2021)
Table 48. China Oral Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 49. China Oral Vaccines Revenue Share by Company (2016-2021)
Table 50. China Oral Vaccines Sales (M Doses) by Type (2016-2021)
Table 51. China Oral Vaccines Sales Share by Type (2016-2021)
Table 52. China Oral Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Oral Vaccines Price (USD/K Doses) by Type (2016-2021)
Table 54. China Oral Vaccines Sales (M Doses) by Type (2022-2027)
Table 55. China Oral Vaccines Sales Share by Type (2022-2027)
Table 56. China Oral Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Oral Vaccines Revenue Share by Type (2022-2027)
Table 58. China Oral Vaccines Price (USD/K Doses) by Type (2022-2027)
Table 59. China Oral Vaccines Sales (M Doses) by Application (2016-2021)
Table 60. China Oral Vaccines Sales Share by Application (2016-2021)
Table 61. China Oral Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Oral Vaccines Price (USD/K Doses) by Application (2016-2021)
Table 63. China Oral Vaccines Sales (M Doses) by Application (2022-2027)
Table 64. China Oral Vaccines Sales Share by Application (2022-2027)
Table 65. China Oral Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Oral Vaccines Revenue Share by Application (2022-2027)
Table 67. China Oral Vaccines Price (USD/K Doses) by Application (2022-2027)
Table 68. North America Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 69. North America Oral Vaccines Sales Market Share by Country (2016-2021)
Table 70. North America Oral Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Oral Vaccines Sales by Region (2016-2021) & (M Doses)
Table 73. Asia Pacific Oral Vaccines Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Oral Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Oral Vaccines Revenue Market Share by Region (2016-2021)
Table 76. Europe Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 77. Europe Oral Vaccines Sales Market Share by Country (2016-2021)
Table 78. Europe Oral Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 80. Latin America Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 81. Latin America Oral Vaccines Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Oral Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 85. Middle East and Africa Oral Vaccines Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Oral Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 88. Merck Corporation Information
Table 89. Merck Description and Business Overview
Table 90. Merck Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 91. Merck Oral Vaccines Product
Table 92. Merck Recent Development
Table 93. GSK Corporation Information
Table 94. GSK Description and Business Overview
Table 95. GSK Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 96. GSK Product
Table 97. GSK Recent Development
Table 98. Sanofi Corporation Information
Table 99. Sanofi Description and Business Overview
Table 100. Sanofi Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 101. Sanofi Product
Table 102. Sanofi Recent Development
Table 103. Lanzhou Institute Corporation Information
Table 104. Lanzhou Institute Description and Business Overview
Table 105. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 106. Lanzhou Institute Product
Table 107. Lanzhou Institute Recent Development
Table 108. Serum Institute Corporation Information
Table 109. Serum Institute Description and Business Overview
Table 110. Serum Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 111. Serum Institute Product
Table 112. Serum Institute Recent Development
Table 113. Valneva Corporation Information
Table 114. Valneva Description and Business Overview
Table 115. Valneva Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 116. Valneva Product
Table 117. Valneva Recent Development
Table 118. Shanghai United Cell Corporation Information
Table 119. Shanghai United Cell Description and Business Overview
Table 120. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 121. Shanghai United Cell Product
Table 122. Shanghai United Cell Recent Development
Table 123. Bibcol Corporation Information
Table 124. Bibcol Description and Business Overview
Table 125. Bibcol Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 126. Bibcol Product
Table 127. Bibcol Recent Development
Table 128. PaxVax Corporation Information
Table 129. PaxVax Description and Business Overview
Table 130. PaxVax Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 131. PaxVax Product
Table 132. PaxVax Recent Development
Table 133. Vabiotech Corporation Information
Table 134. Vabiotech Description and Business Overview
Table 135. Vabiotech Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 136. Vabiotech Product
Table 137. Vabiotech Recent Development
Table 138. Tiantan Biological Corporation Information
Table 139. Tiantan Biological Description and Business Overview
Table 140. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 141. Tiantan Biological Product
Table 142. Tiantan Biological Recent Development
Table 143. EuBiologics Corporation Information
Table 144. EuBiologics Description and Business Overview
Table 145. EuBiologics Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 146. EuBiologics Product
Table 147. EuBiologics Recent Development
Table 148. Panacea Biotec Ltd Corporation Information
Table 149. Panacea Biotec Ltd Description and Business Overview
Table 150. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 151. Panacea Biotec Ltd Product
Table 152. Panacea Biotec Ltd Recent Development
Table 153. Bio-Med Corporation Information
Table 154. Bio-Med Description and Business Overview
Table 155. Bio-Med Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 156. Bio-Med Product
Table 157. Bio-Med Recent Development
Table 158. Halfkin Bio-Pharmaceuticals Corporation Information
Table 159. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 160. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 161. Halfkin Bio-Pharmaceuticals Product
Table 162. Halfkin Bio-Pharmaceuticals Recent Development
Table 163. Oral Vaccines Market Trends
Table 164. Oral Vaccines Market Drivers
Table 165. Oral Vaccines Market Challenges
Table 166. Oral Vaccines Market Restraints
Table 167. Oral Vaccines Customers List
Table 168. Oral Vaccines Distributors List
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. Rotavirus Vaccine Product Picture
Figure 4. Cholera Vaccine Product Picture
Figure 5. Oral Polio Vaccine Product Picture
Figure 6. Global Oral Vaccines Sales Market Share by Application in 2020 & 2027
Figure 7. Public
Figure 8. Private
Figure 9. Oral Vaccines Report Years Considered
Figure 10. Global Oral Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Oral Vaccines Market Size 2016-2027 (US$ Million)
Figure 12. Global Oral Vaccines Sales 2016-2027 (M Doses)
Figure 13. Global Oral Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Oral Vaccines Sales Market Share by Region (2016-2021)
Figure 15. Global Oral Vaccines Sales Market Share by Region in 2020
Figure 16. Global Oral Vaccines Revenue Market Share by Region (2016-2021)
Figure 17. Global Oral Vaccines Revenue Market Share by Region in 2020
Figure 18. Global Oral Vaccines Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Oral Vaccines Revenue in 2020
Figure 20. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Oral Vaccines Sales Market Share by Type (2016-2021)
Figure 22. Global Oral Vaccines Sales Market Share by Type in 2020
Figure 23. Global Oral Vaccines Revenue Market Share by Type (2016-2021)
Figure 24. Global Oral Vaccines Revenue Market Share by Type in 2020
Figure 25. Global Oral Vaccines Sales Market Share by Application (2016-2021)
Figure 26. Global Oral Vaccines Sales Market Share by Application in 2020
Figure 27. Global Oral Vaccines Revenue Market Share by Application (2016-2021)
Figure 28. Global Oral Vaccines Revenue Market Share by Application in 2020
Figure 29. China Oral Vaccines Sales Growth Rate 2016-2027 (M Doses)
Figure 30. China Oral Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Oral Vaccines Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Oral Vaccines Players Market Share by Revenue in Oral Vaccines in 2020
Figure 33. China Oral Vaccines Revenue Share by Type (2016-2021)
Figure 34. China Oral Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Oral Vaccines Revenue Share by Application (2016-2021)
Figure 36. China Oral Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Oral Vaccines Sales Growth Rate 2016-2021 (M Doses)
Figure 38. North America Oral Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Oral Vaccines Sales Market Share by Country in 2020
Figure 40. North America Oral Vaccines Revenue Market Share by Country in 2020
Figure 41. U.S. Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 42. U.S. Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 44. Canada Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Oral Vaccines Sales Growth Rate 2016-2021 (M Doses)
Figure 46. Europe Oral Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Oral Vaccines Sales Market Share by Country in 2020
Figure 48. Europe Oral Vaccines Revenue Market Share by Country in 2020
Figure 49. Germany Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 50. Germany Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 52. France Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 54. U.K. Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 56. Italy Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 58. Russia Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Oral Vaccines Sales Growth Rate 2016-2021 (M Doses)
Figure 60. Asia Pacific Oral Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Oral Vaccines Sales Market Share by Region in 2020
Figure 62. Asia Pacific Oral Vaccines Revenue Market Share by Region in 2020
Figure 63. China Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 64. China Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 66. Japan Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 68. South Korea Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 70. India Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 72. Australia Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 74. Taiwan Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 76. Indonesia Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 78. Thailand Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 80. Malaysia Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 82. Philippines Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 84. Vietnam Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Oral Vaccines Sales Growth Rate 2016-2021 (M Doses)
Figure 86. Latin America Oral Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Oral Vaccines Sales Market Share by Country in 2020
Figure 88. Latin America Oral Vaccines Revenue Market Share by Country in 2020
Figure 89. Mexico Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 90. Mexico Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 92. Brazil Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 94. Argentina Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Oral Vaccines Sales Growth Rate 2016-2021 (M Doses)
Figure 96. Middle East and Africa Oral Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Oral Vaccines Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Oral Vaccines Revenue Market Share by Country in 2020
Figure 99. Turkey Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 100. Turkey Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 102. Saudi Arabia Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. U.A.E Oral Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 104. U.A.E Oral Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Oral Vaccines Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
経口ワクチンの世界市場 2020年 Market Overview The Oral Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…- 経口ポリオワクチン（OPV）の世界市場 2020年 Market Overview The global Oral Polio Vaccines (OPV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Polio Vaccines…
- 渡航者用ワクチンの世界市場 2020年 Market Overview The Travelers Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 牛呼吸器ワクチンの世界市場 2020年 Market Overview The global Cattle Respiratory Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cattle Respirator…
- mRNAワクチン・治療薬の世界市場 2020年 Market Overview The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…